421 related articles for article (PubMed ID: 15768350)
21. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.
Chu FY; Chiang SC; Su FH; Chang YY; Cheng SH
J Med Virol; 2009 Jun; 81(6):973-8. PubMed ID: 19382252
[TBL] [Abstract][Full Text] [Related]
22. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
[TBL] [Abstract][Full Text] [Related]
23. Centers for Disease Control and Prevention initiatives to prevent hepatitis C virus infection: a selective update.
Smith BD; Jorgensen C; Zibbell JE; Beckett GA
Clin Infect Dis; 2012 Jul; 55 Suppl 1():S49-53. PubMed ID: 22715214
[TBL] [Abstract][Full Text] [Related]
24. A framework for management of hepatitis C in prisons.
Spaulding AC; Weinbaum CM; Lau DT; Sterling R; Seeff LB; Margolis HS; Hoofnagle JH
Ann Intern Med; 2006 May; 144(10):762-9. PubMed ID: 16702592
[TBL] [Abstract][Full Text] [Related]
25. Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland.
Hutchinson SJ; Bird SM; Goldberg DJ
Hepatology; 2005 Sep; 42(3):711-23. PubMed ID: 16116637
[TBL] [Abstract][Full Text] [Related]
26. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
Cullen W; Stanley J; Langton D; Kelly Y; Bury G
Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
[TBL] [Abstract][Full Text] [Related]
27. Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities.
Litwin AH; Soloway I; Gourevitch MN
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S339-45. PubMed ID: 15768345
[TBL] [Abstract][Full Text] [Related]
28. Delivering therapy for hepatitis C virus infection to incarcerated HIV-seropositive patients.
McGovern B; Fiore J; Wurcel A; Taglienti P; Bradley M; Galvin S; Libone G; Ramsey J; Molinaro-Gudas V; Drewniak S; Amick C; Andalkar A; Scheft H; Bica I
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S56-62. PubMed ID: 16265615
[TBL] [Abstract][Full Text] [Related]
29. Planning a hepatitis C postexposure management program for health care workers. Issues and challenges.
Haiduven DJ
AAOHN J; 2000 Aug; 48(8):370-5. PubMed ID: 11760299
[TBL] [Abstract][Full Text] [Related]
30. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER; Bi P; Ryan P
Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
[TBL] [Abstract][Full Text] [Related]
32. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus infection among methamphetamine-dependent individuals in outpatient treatment.
Gonzales R; Marinelli-Casey P; Shoptaw S; Ang A; Rawson RA
J Subst Abuse Treat; 2006 Sep; 31(2):195-202. PubMed ID: 16919748
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of hepatitis C infection and its public health implications in Puerto Rico.
Pérez CM; Suárez E; Torres EA
P R Health Sci J; 2004 Jun; 23(2 Suppl):11-28. PubMed ID: 16929583
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus infection: an overview of Wisconsin's public health resources.
Hurie M; Reiser WJ; Vergeront J
WMJ; 2006 Jan; 105(1):30-3. PubMed ID: 16676488
[TBL] [Abstract][Full Text] [Related]
36. Outcome of screening for hepatitis C virus infection based on risk factors.
Mallette C; Flynn MA; Promrat K
Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
[TBL] [Abstract][Full Text] [Related]
37. Healthcare resources are inadequate to address the burden of illness among HIV-infected male prisoners in Malaysia.
Bick J; Culbert G; Al-Darraji HA; Koh C; Pillai V; Kamarulzaman A; Altice F
Int J Prison Health; 2016 Dec; 12(4):253-269. PubMed ID: 27921633
[TBL] [Abstract][Full Text] [Related]
38. Five Questions Concerning Managing Hepatitis C in the Justice System: Finding Practical Solutions for Hepatitis C Virus Elimination.
Spaulding AC; Adee MG; Lawrence RT; Chhatwal J; von Oehsen W
Infect Dis Clin North Am; 2018 Jun; 32(2):323-345. PubMed ID: 29778259
[TBL] [Abstract][Full Text] [Related]
39. An epidemiologic summary of the hepatitis C epidemic in Minnesota.
Fong F
Minn Med; 2003 Jun; 86(6):46-51. PubMed ID: 12834214
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus prevention, care, and treatment: from policy to practice.
Ward JW; Valdiserri RO; Koh HK
Clin Infect Dis; 2012 Jul; 55 Suppl 1():S58-63. PubMed ID: 22715216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
